Literature DB >> 26216129

Mesenchymal Stem Cells: Key Actors in Tumor Niche.

Sanaa El Marsafy1, Jérôme Larghero.   

Abstract

Tumors grow in privileged microenvironment referred to as the cancer niche. This niche is composed of cancer cells and various components including mesenchymal stem cells (MSC), fibroblasts, network of microvasculature added to innate and primed immune cells. Additionally, it encloses other elements such as the extracellular matrix (ECM), cytokines, chemokines and growth factors. Crosstalk between cancer cells and different niche constituents is crucial for tumor growth and metastasis. Herein, we focus attention on the bidirectional relationship between MSC and cancer cells and its impact on tumor progression. Better comprehension of these events within the tumor niche might be valuable for developing effective anti-tumor therapeutic strategies.

Entities:  

Mesh:

Year:  2015        PMID: 26216129     DOI: 10.2174/1574888x10666150728121528

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  5 in total

Review 1.  Extracellular vesicles as regulators of tumor fate: crosstalk among cancer stem cells, tumor cells and mesenchymal stem cells.

Authors:  Rafael Soares Lindoso; Federica Collino; Adalberto Vieyra
Journal:  Stem Cell Investig       Date:  2017-09-16

2.  Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer.

Authors:  Tahir Muhammad; Ali Sakhawat; Aamir Ali Khan; Ling Ma; Ruth A Gjerset; Yinghui Huang
Journal:  Stem Cell Res Ther       Date:  2019-06-25       Impact factor: 6.832

3.  Peritumoral administration of IFNβ upregulated mesenchymal stem cells inhibits tumor growth in an orthotopic, immunocompetent rat glioma model.

Authors:  Jiaji Mao; Minghui Cao; Fang Zhang; Jingzhong Zhang; Xiaohui Duan; Liejing Lu; Zehong Yang; Xiang Zhang; Wangshu Zhu; Qinyuan Zhang; Zhe Wang; Jun Shen
Journal:  J Immunother Cancer       Date:  2020-03       Impact factor: 13.751

4.  Chondrogenic primed extracellular vesicles activate miR-455/SOX11/FOXO axis for cartilage regeneration and osteoarthritis treatment.

Authors:  Ye Sun; Jie Zhao; Qiang Wu; Yuxin Zhang; Yongqing You; Wenbo Jiang; Kerong Dai
Journal:  NPJ Regen Med       Date:  2022-09-16

5.  Mesenchymal Stromal Cells-Derived β2-Microglobulin Promotes Epithelial-Mesenchymal Transition of Esophageal Squamous Cell Carcinoma Cells.

Authors:  Junjie Wang; Weilin Yang; Tao Wang; Xiaoyong Chen; Jiancheng Wang; Xiaoran Zhang; Chuang Cai; Beilong Zhong; Jiabin Wu; Zhenguang Chen; Andy Peng Xiang; Weijun Huang
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.